Pelvic Neoplasms: Clinical Trials

5 trials for Pelvic Neoplasms, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 2 recruiting. 5 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 35Completed 3, Recruiting 2

Follow Pelvic Neoplasms: new trials by email Literature Review of Pelvic Neoplasms trials Research Report on Pelvic Neoplasms

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
An Imaging Agent (Pafolacianine) for Identifying Lesions in Pediatric Patients With Primary or Metastatic Solid Tumors
Biospecimen Collection, Near Infrared Imaging, Pafolacianine Sodium - Childhood Malignant Solid Neoplasm, Childhood Malignant Thoracic Neoplasm
Phase 3RecruitingMayo Clinic202025-04-152026-10-30
BladdEr Full OR Empty for Pelvic Radiation Therapy
Radiation therapy - Pelvic Neoplasm
Phase 3RecruitingUniversity of California, San Diego3002024-11-192026-02-17
Trial of Collagen Mesh for Prevention of Ventral Hernia After Surgery for Advanced Pelvic Cancer
Mesh repair, Conventional facial closure - Incisional Hernia, Pelvic Cancer
Phase 3CompletedUniversity of Aarhus592008-04-012013-09-09
An Ovarian, Primary Peritoneal or Fallopian Tube Cancer Study for Patients That Have Not Received Prior Chemotherapy
Gemcitabine, Paclitaxel, Carboplatin - Genital Neoplasms, Female, Fallopian Tube Neoplasms
Phase 3CompletedEli Lilly and Company9192002-10-012011-03-04
A Randomized Trial for Patients With Platinum Resistant Ovarian, Fallopian or Primary Peritoneal Cancer.
Gemcitabine, liposomal doxorubicin - Genital Neoplasms, Female, Fallopian Tube Neoplasms
Phase 3CompletedEli Lilly and Company1622002-07-012007-01-26

Narrower conditions

Fallopian Tube Neoplasms (2)  ·  Genital Neoplasms, Female (2)  ·  Ovarian Neoplasms (2)  ·  Peritoneal Neoplasms (2)  ·  Head and Neck Neoplasms (1)  ·  Incisional Hernia (1)

Broader conditions

Neoplasms (5)  ·  Neoplasms by Site (5)  ·  Abdominal Neoplasms (2)  ·  Adnexal Diseases (2)  ·  Digestive System Diseases (2)  ·  Digestive System Neoplasms (2)  ·  Endocrine Gland Neoplasms (2)  ·  Endocrine System Diseases (2)  ·  Fallopian Tube Diseases (2)  ·  Female Urogenital Diseases (2)  ·  Female Urogenital Diseases and Pregnancy Complications (2)  ·  Genital Diseases (2)  ·  Genital Diseases, Female (2)  ·  Gonadal Disorders (2)  ·  Ovarian Diseases (2)

Interventions

Gemcitabine (2)  ·  Carboplatin (1)  ·  Paclitaxel (1)  ·  Pafolacianine (1)  ·  Radiotherapy (1)  ·  Specimen Handling (1)  ·  Surgical Procedures, Operative (1)  ·  liposomal doxorubicin (1)

Sponsors

Eli Lilly and Company (2)  ·  Mayo Clinic (1)  ·  University of Aarhus (1)  ·  University of California, San Diego (1)

Countries

United States (4)  ·  Denmark (1)  ·  Puerto Rico (1)

Top investigators

Peter Christensen, M.D., Ph.d (1)  ·  Stephanie F. Polites, MD, MPH (1)  ·  Tyler Seibert, MD, PhD (1)

Results publications

PMID 37407274